Arrowhead Pharmaceuticals (ARWR) Earnings Date, Estimates & Call Transcripts $17.71 -1.20 (-6.35%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$18.08 +0.38 (+2.12%) As of 03/3/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Arrowhead Pharmaceuticals Latest Earnings SummaryUpcoming Q2 Earnings DateMay. 8After Market ClosesEstimatedActual EPS (Feb. 10) -$1.39 Missed By -$0.97 Consensus EPS (Feb. 10) -$0.42 Arrowhead Pharmaceuticals released Q1 2025 earnings on February 10, 2025, reporting an EPS of -$1.39, which missed analysts' consensus estimates of -$0.42 by $0.97. With a trailing EPS of -$5.17, Arrowhead Pharmaceuticals' earnings are expected to decrease next year, from ($2.42) to ($3.16) per share. Conference CallConference Call TranscriptARWR Upcoming EarningsArrowhead Pharmaceuticals' next earnings date is estimated for Thursday, May 8, 2025, based off prior year's reporting schedules. Get Arrowhead Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Arrowhead Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataARWR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ARWR Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Arrowhead Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20251-$1.07-$1.07-$1.07 Q2 20254-$1.01$2.66$0.18 Q3 20253-$1.01-$0.29-$0.53 Q4 20254-$1.02$0.39-$0.46 FY 202512($4.11)$1.69 ($1.89) Arrowhead Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)-------2/10/2025Q1 2025-$0.42-$1.39 -$0.97-$1.39$19.05M-8/8/2024Q3 2024-$0.58-$1.38 -$0.80-$1.38$52.87M-5/9/2024Q2 2024-$0.06-$1.02 -$0.96-$1.02$41.97M-2/6/2024Q1 2024-$0.78-$1.24 -$0.46-$1.24$35.60M$3.55M11/29/2023Q4 2023-$0.70-$1.03 -$0.33-$1.03$38.87M$16.10M8/7/2023Q3 2023-$0.58-$0.96 -$0.38-$0.96$45.42M$15.83M5/2/2023Q2 2023-$0.65$0.45+$1.10$0.45$45.48M$146.27M Arrowhead Pharmaceuticals Earnings - Frequently Asked Questions When is Arrowhead Pharmaceuticals's earnings date? Arrowhead Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on ARWR's earnings history. Did Arrowhead Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Arrowhead Pharmaceuticals (NASDAQ:ARWR) missed the analysts' consensus estimate of ($0.42) by $0.97 with a reported earnings per share (EPS) of ($1.39). Learn more on analysts' earnings estimate vs. ARWR's actual earnings. How can I listen to Arrowhead Pharmaceuticals's earnings conference call? The conference call for Arrowhead Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Arrowhead Pharmaceuticals's conference call transcript? The conference call transcript for Arrowhead Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Arrowhead Pharmaceuticals generate each year? Arrowhead Pharmaceuticals (NASDAQ:ARWR) has a recorded annual revenue of $2.50 million. How much profit does Arrowhead Pharmaceuticals generate each year? Arrowhead Pharmaceuticals (NASDAQ:ARWR) has a recorded net income of -$599.49 million. ARWR has generated -$5.17 earnings per share over the last four quarters. What is Arrowhead Pharmaceuticals's EPS forecast for next year? Arrowhead Pharmaceuticals's earnings are expected to decrease from ($2.42) per share to ($3.16) per share in the next year. More Earnings Resources from MarketBeat Related Companies ASND Earnings Results QGEN Earnings Results ROIV Earnings Results RVMD Earnings Results BBIO Earnings Results LEGN Earnings Results AXSM Earnings Results BPMC Earnings Results CYTK Earnings Results NUVL Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Analysts Lift Archer Aviation Stock Despite Earnings Miss DigitalOcean Rides Cloud Wave and AI Hype to Strong EarningsPrice Targets on NVIDIA Rise in Front of EarningsThe Trade Desk Crashes on Earnings, But Growth Catalysts PersistHims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before EarningsAirbnb's Earnings: Sky High Results, Grounded Guidance? This page (NASDAQ:ARWR) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredIgnore Fox Business’s “man who calls it all” at your perilThis is the biggest AI investment story you’ve never been told… and people who invest before March 19 could st...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arrowhead Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arrowhead Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ARWR Stock Alerts